Emily Walsh Martin, PhD, spoke with Amber Freed, founder and CEO of SLC6A1 Connect, a patient organization focused on accelerating the development of therapies for SLC6A1 patients like her son Maxwell.

The biological clock of aging and the possibility of lifespan extension with Christin Glorioso and John Bell
39:13

Against the Odds: How Dr. Anna Maurer Built a Life in Science
33:17

A Discussion on the Past, Present, and Future Promise of Gene Editing with Fyodor Urnov, PhD
45:46